Skip to content

Phibro Animal Health PAHC Income Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$383.54M+2.6%$373.91M+2.8%$363.89M-3.9%$378.7M+8.9%$347.83M+12.5%
$257.87M+6.9%$241.25M-1.2%$244.11M-9.1%$268.69M+10.5%$243.26M+17.3%
$125.68M-5.3%$132.66M+10.7%$119.78M+8.9%$110.01M+5.2%$104.57M+2.6%
32.8%-2.7pp35.5%+2.6pp32.9%+3.9pp29%-1.0pp30.1%-2.9pp
$81.02M-1.6%$82.33M+20.1%$68.52M-10.2%$76.29M+7.4%$71.05M-6.9%
$44.65M-11.3%$50.33M-1.8%$51.26M+52.0%$33.72M+0.6%$33.52M+31.3%
11.6%-1.8pp13.5%-0.6pp14.1%+5.2pp8.9%-0.7pp9.6%+1.4pp
-$10.43M+11.3%-$11.76M+2.5%-$12.06M-40.1%-$8.61M+8.0%-$9.36M-4.0%
-$1.91M+11.0%-$2.15M+26.9%-$2.93M-133%-$1.26M-123%$5.53M+147%
$32.31M-11.3%$36.43M+0.4%$36.27M+52.1%$23.85M-19.7%$29.69M+514%
$8.29M-7.6%$8.97M-7.9%$9.74M+47.1%$6.62M-24.8%$8.81M+433%
$24.02M-12.5%$27.46M+3.5%$26.53M+54.0%$17.22M-17.5%$20.88M+556%
6.3%-1.1pp7.3%+0.1pp7.3%+2.7pp4.5%-1.5pp6%+5.0pp
$0.59-11.9%$0.67+3.1%$0.65+51.2%$0.43-15.7%$0.51+538%
$57.1M-9.7%$63.22M-1.4%$64.09M+38.9%$46.13M0.0%$46.13M+24.3%
14.9%-2.0pp16.9%-0.7pp17.6%+5.4pp12.2%-1.1pp13.3%+1.3pp
$44.65M-11.3%$50.33M-1.8%$51.26M+52.0%$33.72M+0.6%$33.52M+31.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Phibro Animal Health's revenue?
Phibro Animal Health (PAHC) generated $1.5B in revenue over the trailing twelve months, up 26.0% year over year.
Is Phibro Animal Health profitable?
Phibro Animal Health reported $95.2M in net income over the trailing twelve months, a 6.3% net margin.
What are Phibro Animal Health's profit margins?
Gross margin is 32.5% and operating margin is 12.0%, with a 6.3% net margin.
What is Phibro Animal Health's earnings per share?
Phibro Animal Health's diluted EPS over the trailing twelve months is $2.34.
Where does Phibro Animal Health's income statement data come from?
Every line is extracted from Phibro Animal Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.